By Allison Martell TORONTO (Reuters) – Italy’s Recordati said on Tuesday it plans to seek Canadian approval for its drug Cystagon, which treats a rare kidney disease, in a potential blow to Horizon Pharma,, which...
Read More
Reductions seen in risk for kidney failure, cardiovascular disease with canagliflozin versus placebo
Read More
Patients with pruritus have higher prevalence of patient-reported depression, restless sleep
Read More
Active surveillance (AS) for patients with prostate cancer include follow-up with serial prostate...
Read More
Effective, compassionate communication with patients can quickly help form a trusting relationship...
Read More
